Columbia University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Columbia University sits in the top decile of US sponsors by registered trial count (#34 of 15,742 sponsors by registered trial count).
Columbia University: 958 sponsored US clinical trials, 171 recruiting.
Columbia University sponsors 958 registered US clinical trials on ClinicalTrials.gov, 171 of them currently recruiting, and 597 completed. 88 of these trials are in Phase 3-4 (later-stage) and 191 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 9 trials.
Top-decile sponsor footprint
Columbia University ranks in the top decile of sponsors by registered trial count (#34 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
597 of 736 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
958 total, page 5 of 20
Comparison of the Breast Tumor Microenvironment
NCT03165487
Intraoperative Radiation Therapy (IORT) in DCIS
NCT03216421
Low GI Diet in Children and Adolescents With ALL
NCT03157323
Treatment of TK2 Deficiency With Thymidine and Deoxycytidine
NCT03639701
Northern Manhattan Study of Metabolism and Mind
NCT02470260
Stem Cell Transplant in Sickle Cell Disease and Thalassemia
NCT00408447
Neuronavigation-guided FUS-induced BBB Opening in Alzheimer's Disease Patients and Its Effects on Brain Amyloid and Tau
NCT06600880
Human Models of Selective Insulin Resistance: Pancreatic Clamp
NCT06558422
Evaluation of Three Pulp Vitality Tests
NCT02636504
HIV/STI/HCV Testing and Overdose Prevention Among Survivors of Sex Trafficking
NCT07264582
Migraine Headaches Elimination With Patent Foramen Ovale-Directed Therapy
NCT07629635
Morphine or Ketamine for Analgesia
NCT06835504
Conservative Versus Operative - First Time Shoulder Dislocations
NCT05532150
Anterior Cruciate Ligament (ACL) Reconstruction With Bone Tendon Bone Autograft With Versus Without Internal Bracing
NCT05532189
Conservative Versus Operative - First Time Patella Dislocations
NCT05533671
Adaptive Recruitment Curve Analysis Using Bayesian Modeling
NCT07561372
Music Intervention for Preterm Birth
NCT05945264
Know Your Pressures NYC
NCT05992415
Post-op Prednisone and Glucose Monitoring in TKA
NCT07630896
Bilevel Positive Airway Pressure (BPAP) for Severe Asthma
NCT07582211
Adding Dexmedetomidine or Clonidine to Spinal Anesthesia for Cesarean Delivery
NCT07567495
EEG-Guided Analgesic Titration During General Anesthesia to Improve Early Neurocognitive Recovery in Older Patients
NCT04443517
Sleep in Collegiate Baseball Players
NCT07212101
Efficacy of Nanodropper-mediated Topical Anesthetic
NCT06636708
Synbiotic Therapy for NP-PASC
NCT06620406
TechMPower: Advancing HIV/SUD Care and Service Delivery for People in Re-entry
NCT07088770
Text4Vax: Text Message Reminders for Pediatric COVID-19 and Influenza Vaccines 2024-25 Season
NCT06603090
Feasibility of an Oral Intervention for Sexual Health in Transgender Men
NCT06470906
E-mails to Nudge Safer and Better-Informed Prescribing of Risky Drugs
NCT06443385
Probiotic Chocolate Study in Multiple Sclerosis
NCT06475183
Free Time For Wellness Pilot Effectiveness Trial
NCT06474715
Community Health Worker Assisted Task Specific and Cognitive Therapy at Home With Exposure After Stroke
NCT06314308
Data-driven SDM to Reduce Symptom Burden in AF
NCT04993807
Role of Insulin Action in Psoriasis Pathogenesis
NCT06242847
Using Shared Decision Making to Improve Kidney Transplantation Rates
NCT06141499
Characterizing and Addressing Financial Toxicity in AYAs With Cancer
NCT06072833
Sepsis Electronic Prompting for Timely Intervention and Care for Emergency Department Patients
NCT06117605
Sepsis Electronic Prompting for Timely Intervention and Care for Inpatients
NCT06117618
Messy Memories: Mobile Application Therapy Following Critical Illness
NCT05849454
mLab App Plus: A Randomized Controlled Trial of a Mobile Health (mHealth) Intervention
NCT06059443
Body Electric: a Pragmatic Trial Evaluating the Viability of Movement Breaks
NCT06592209
Restoring Energy With Sub-symptom Threshold Optimized Rehabilitation Exercise for Long COVID
NCT06172803
Siplizumab for Sickle Cell Disease Transplant
NCT06078696
A Digital Patient Decision Aid to Increase Sexually Transmitted Infection Testing in the Emergency Department: The STIckER Study
NCT06014177
Nurse Suicide: Physiologic Sleep Health Promotion Trial
NCT06079853
Removing Surrogates' Uncertainty to Reduce Fear and Anxiety After Cardiac Events
NCT06048068
Pancreatic Clamp in NAFLD
NCT05724134
A Skin Glue Versus Subcuticular Suture for Cesarean Closure Study
NCT05903547
Improving Patient Prioritization During Hospital-homecare Transition
NCT04136951
Glycemic Effect of Diazoxide in NAFLD
NCT05729282
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 86 |
| Phase 2 | 105 |
| Phase 3 | 23 |
| Phase 4 | 65 |
Therapeutic Areas
What is open in the Columbia University pipeline
171 recruiting of 958 indexed (18% open); 597 completed (62%).
Phase mix: 88 late (III/IV) vs 191 early (I/II) (early-phase heavy).
Top condition: Obesity (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Columbia University: open-pipeline peers nationwide
Peers matched on 958 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Columbia University sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 958 trials (± recruiting share)
- University of Minnesota · 966 trials · 19% recruiting
- Brigham and Women's Hospital · 937 trials · 15% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- University of California, Los Angeles · 897 trials · 18% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Kite, A Gilead Company · 18% recruiting · 28 trials
- Mirum Pharmaceuticals · 18% recruiting · 28 trials
- West Virginia University · 18% recruiting · 122 trials
- Hospital for Special Surgery, New York · 18% recruiting · 194 trials
Related
What to do with this Columbia University page
958 registered trials is a research-attention snapshot, not an endorsement of Columbia University or any single study.
- 171 of Columbia University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Columbia University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Columbia University pipeline card: 958 registered trials from official public datasets.Report a data error.